BRACCI, CRISTIANO
 Distribuzione geografica
Continente #
NA - Nord America 329
EU - Europa 245
AS - Asia 136
AF - Africa 7
OC - Oceania 1
Totale 718
Nazione #
US - Stati Uniti d'America 325
IT - Italia 116
CN - Cina 45
SE - Svezia 37
SG - Singapore 37
IE - Irlanda 22
DE - Germania 19
UA - Ucraina 15
VN - Vietnam 13
FR - Francia 12
ID - Indonesia 10
RS - Serbia 9
JP - Giappone 8
EG - Egitto 7
GB - Regno Unito 6
IN - India 6
KR - Corea 6
HK - Hong Kong 4
PK - Pakistan 4
FI - Finlandia 3
BE - Belgio 2
CA - Canada 2
ES - Italia 2
IR - Iran 2
MX - Messico 2
AT - Austria 1
AU - Australia 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 718
Città #
Chandler 71
Torino 37
Turin 29
Ashburn 26
Dublin 22
Beijing 21
Singapore 20
Nyköping 17
Dearborn 16
Fairfield 15
Dong Ket 13
Jakarta 10
Woodbridge 10
Wilmington 9
Fremont 8
Jacksonville 7
Nanjing 7
Novi Sad 7
Seattle 7
Eitensheim 6
Milan 6
Princeton 6
Santa Clara 6
Seoul 5
Cambridge 4
Hamburg 4
Houston 4
Lahore 4
Munich 4
San Diego 4
Ann Arbor 3
Guangzhou 3
Hong Kong 3
Medford 3
San Mateo 3
Slough 3
Tanta 3
Valmacca 3
Anderlecht 2
Belgrade 2
Bengaluru 2
Boston 2
Cairo 2
Gainesville 2
Genoa 2
Hangzhou 2
Helsinki 2
Kunming 2
La Paz 2
Madrid 2
Paris 2
Pune 2
Redwood City 2
Rome 2
Tehran 2
Toronto 2
Torre Pellice 2
Tsukuba 2
Bari 1
Bhubaneswar 1
Brusnengo 1
Caselle Torinese 1
Castelletto Sopra Ticino 1
Cedar Knolls 1
Chaville 1
Chennai 1
Cologne 1
Darmstadt 1
Edinburgh 1
Fragagnano 1
Frankfurt am Main 1
Guiyang 1
Hebei 1
Huntington Beach 1
Lappeenranta 1
Lincoln 1
Los Angeles 1
Moscow 1
Mountain View 1
Norwalk 1
Osaka 1
Qinhuangdao 1
Redmond 1
Richmond 1
San Francisco 1
San Jose 1
San Mauro Torinese 1
Silver Spring 1
Suita 1
Taipei 1
Vienna 1
Warren 1
Washington 1
Xian 1
Totale 505
Nome #
Expression, Functions and Potential Therapeutic Implications of CD157 in Acute Myeloid Leukemia 140
CD157: From Myeloid Cell Differentiation Marker to Therapeutic Target in Acute Myeloid Leukemia. 122
Flow-cytometry and functional evaluation of the CD39/CD73 adenosinergic immunosuppressive axis in patients with Sézary syndrome 121
CD157 reduces acutemyeloid leukemia cell sensitivity tocytarabine through upregulation of MCL-1 anti-apoptotic protein 112
CD157 REGULATES THE SENSITIVITY OF ACUTE MYELOID LEUKEMIA CELLS TO CHEMOTHERAPY BY MODULATING THE APOPTOTIC RESPONSE 101
CD157 signaling promotes survival of acute myeloid leukemia cells and modulates sensitivity to cytarabine through regulation of anti-apoptotic Mcl-1. 74
CD73/Adenosine Pathway Involvement in the Interaction of Non-Small Cell Lung Cancer Stem Cells and Bone Cells in the Pre-Metastatic Niche 32
CD39/CD73 dysregulation and adenosine metabolism contribute to T cell immunosuppression in patients with Sézary syndrome 27
The Circular Life of Human CD38: From Basic Science to Clinics and Back 12
CD38, a Receptor with Multifunctional Activities: From Modulatory Functions on Regulatory Cell Subsets and Extracellular Vesicles, to a Target for Therapeutic Strategies 7
Totale 748
Categoria #
all - tutte 2.835
article - articoli 0
book - libri 0
conference - conferenze 1.021
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.856


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202086 0 0 0 10 12 15 13 12 7 7 3 7
2020/2021109 8 9 17 8 6 6 4 3 16 6 5 21
2021/2022141 4 2 4 6 15 3 10 16 8 29 29 15
2022/2023214 19 30 4 30 18 29 19 15 25 5 14 6
2023/2024131 18 20 12 14 5 15 4 11 1 9 7 15
2024/202567 12 27 23 5 0 0 0 0 0 0 0 0
Totale 748